ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

Professional Societies: Organizations Form Alliance To Call For Quality Cancer Care

October 9, 1998

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989